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Lower extremity arterial disease (LEAD) is a highly prevalent disease affecting 202 million 
people worldwide. Internal iliac artery stenosis (IIAS) is one of the localization of LEAD. 
This diagnosis is often neglected when a patient has a proximal walking pain since most 
physicians evoke a pseudoclaudication. Surprisingly, IIAS management is reported 
neither in the Trans-Atlantic Inter-Society Consensus II nor in the report of the American 
College Foundation/American Heart Association guidelines. The aims of this review are 
to present the current knowledge about the disease, how should it be managed in 2015 
and what are the future research trends.
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Lower extremity arterial disease (LEAD) is a highly prevalent disease mainly caused by atherosclero-
sis, a systemic disease process that alters the normal structure and function of the vessels (1). Thus, 
LEAD risk factors are well identified: non-modifiable risk factors such as age, gender, and heredity; 
and modifiable risk factors such as smoking, hypertension, diabetes, and dyslipidemia (2).
It is common to define proximal LEAD and distal LEAD depending on the ischemia area supplied 
by the damage artery (3). Twenty to 50% LEAD patients are asymptomatic (4). When the claudica-
tion is present, the distal LEAD is typically characterized by calf pain and relies on either common 
iliac lesion and/or external iliac artery and/or femoropopliteal lesions (2). Contrary to distal LEAD, 
the proximal LEAD is characterized by lower back, hip, buttock, or thigh pain and relies on either 
common iliac and/or isolated internal iliac lesions (2, 3, 5, 6).
Internal iliac artery stenosis (IIAS) is one of the possible localizations of atherosclerosis on the 
arterial tree. This disease is often missed in the diagnosis process when a patient has a proximal 
walking pain. Indeed, a pain that appears during walking and involves the lower back, hip, buttock, 
or thigh suggests either proximal claudication or proximal pseudoclaudication (2). Claudication is a 
vasculogenic pain whereas pseudoclaudication results from diseases such as lumbar spinal stenosis, 
hip osteoarthritis, venous congestion, or bone metastasis, sciatica, and so on (7–9) (Figure 1; Table 1).
Unfortunately, due to nearly similar symptoms, the vascular origin is largely neglected when a 
patient has a proximal limb pain since most physicians evoke a pseudoclaudication (9).
Several explanations can be proposed. First, claudication was historically defined by a fatigue, 
discomfort, or pain occurring in calves during effort due to exercise-induced ischemia and which is 
relieved with rest (10). Second, ankle-brachial index (ABI) is used as the standard for the diagnosis of 
LEAD (11). Indeed, LEAD is defined by an ABI ≤0.90 (11), but the latter can remain within normal 
limit in case of isolated IIAS (12) or superior gluteal artery lesions (13). Finally, IIAS management 
is reported neither in the Trans-Atlantic Inter-Society Consensus II (TASC II) nor in the report of 
TABLe 1 | Differential diagnosis of internal iliac artery stenosis.
Potential 
disease
Location 
of pain or 
discomfort
Characteristic 
discomfort
exercise-
induced 
discomfort
effect of rest effect of body 
position
Other characteristics
Arterial 
atherosclerotic 
disease 
(intermittent 
claudication)
Buttock, hip, 
lower back, 
thigh
Cramping, aching, 
fatigue, weakness, or 
frank pain
Yes Rapid relief with rest None Presence of cardiovascular risk 
factors
Spinal stenosis Buttock, hip, 
thigh
Cramping, aching, 
fatigue, weakness or 
tingling or clumsiness
Variable Relieved by sitting or 
changing position
Relief by lumbar 
spine flexion (sitting 
or stooping forward)
History of back problems
Hip osteoarthritis Buttock, hip, 
thigh
Aching Variable Not rapid relief (and may 
be present at rest)
More comfortable 
sitting
Related to activity level, weather 
changes
Bone metastasis At the bone 
level
Aching Variable Not rapid relief (and may 
be present at rest)
Avoid direct pressure 
on bones
History of cancer
Venous 
congestion
Thigh, groin Tightness, bursting After walking Subsides slowly Relief by elevation History of deep veins thrombosis 
at the inferior cava or iliac level; 
presence of varicoses
Adapted from Hirsh et al. (2) and White C (9).
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the American College Foundation/American Heart Association 
(AHA) guidelines (4, 11).
incidence and Prevalence of iiAS
Incidence and prevalence of IIAS have not been established in 
general population. Although isolated IIAS is probably rare, 
FiGURe 1 | Main causes of proximal claudication and pseudoclaudication.
IIAS is often associated with common iliac artery stenosis. The 
prevalence of proximal claudication is 5–14% in patients with 
mild-to-moderate distal LEAD (5, 14), appears high among 
patients with patent aortobifemoral bypasses (15), approxi-
mately 28%, and nearly 35% of patients after bilateral internal 
iliac artery (IIA) embolization prior to endovascular aneurysm 
repair (16).
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Symptoms and Functional impairment
The main symptom is the lower back, hip, buttock, or thigh claudi-
cation defining the proximal claudication, a fatigue, discomfort, or 
pain occurring in specific muscle groups alimenting by IIA during 
effort due to exercise-induced ischemia and which is relieved with 
rest (2, 6). However, the presentation of proximal claudication is 
often atypical and may mimic other non-vascular diseases that 
may induce misleading diagnoses (5, 9) (Figure 1). Moreover, the 
pain may appear at rest when IIAS is severe, and can lead even 
to gluteal necrosis (17). Finally, IIAS induces different functional 
impairments: walking impairment that leads to work disability, 
and sexual impairment as erectile dysfunction (16, 18). These two 
impairments reduce the patient quality of life (19–21). To avoid 
these impairments, although it is challenging with conventional 
non-invasive tests, it is of interest to diagnose the disease in order 
to diminish the delay of diagnosis, which is currently of 2 years, 
when the disease is not associated with distal LEAD (14).
Strategies and evidences
Clinical evaluation
Patients typically report a gradual decrease of their walking 
capacity, which is evaluated by the maximal walking distance (2). 
Claudication traditionally stops within 10 min after the end of 
walking (22, 23). The maximal walking distance often impairs 
either with the increase of the arterial stenosis or the deteriora-
tion of the functionality of the collateral network, which both 
diminish blood flow delivery to muscles irrigated by the IIA 
(6). The maximal walking distance can be evaluated by different 
methods: medical interview, questionnaires (24), standardized 
treadmill evaluation which is recommended (11), 6-min test 
when patients are unable to walk on a treadmill (11), and recently 
GPS technology (25).
Physical examination should rule out a pseudoclaudication 
(9). Hip osteoarthritis is associated with pain typically in the groin 
provoked by internal or external rotation of the hip (8). The hip 
pain often radiates in the knee, whereas lumbar spinal stenosis is 
associated with discomfort that radiates beyond the spinal area 
into the buttocks (7). Furthermore, active lumbar extension may 
induce discomfort that is relieved with flexion. Finally, pain due 
to bone metastasis is aggravated by direct pressure on bones.
Different questionnaires have been developed to help clinicians 
to distinguish vascular claudication from pseudoclaudication. 
The most used are the World Health Organization (WHO)/Rose 
Questionnaire, the Edinburgh claudication questionnaire, and 
the San Diego questionnaire (22, 26, 27) [Readers will find these 
entire questionnaires in the same article published in Vascular 
Medicine (28)].
Pulse palpations, auscultation of lower limbs, and abdomen 
looking for a vascular breath have to be done on patient (2).
The ABI measurement defined as the highest systolic pressure 
in the dorsalis pedis or posterior tibial artery divided by the high-
est arm pressure measurement can be helpful, although it may be 
insensitive in the case of isolated internal iliac lesions (11, 12).
The penile pressure measurement has been suggested to be an 
alternative method to diagnose proximal arteries stenosis (29). 
Penile-brachial index (PBI), defined as penile pressure over the 
highest systolic brachial ratio, is rarely used in routine investi-
gations, and its accuracy is 69.3% (95% confidence interval: 
58.6–78.7) for the detection of an arterial stenosis or occlusion 
on at least one side as compared with the arteriograms (30). 
Therefore, a normal PBI (>0.60) cannot rule out the presence of 
lesions on the internal iliac arteries (30).
Classical Imaging
Duplex ultrasound (DUS) of the vascular abdominal circula-
tion may help to evoke the diagnosis (11) (Table 2). Indeed, the 
sensitivity and specificity of DUS to assess aorto-iliac disease 
(stenoses) when compared with arteriography are 91% and 93%, 
respectively (31). However, no study has evaluated the sensitiv-
ity and specificity of DUS in the specific assessment of IIAS. 
Sensitivity and specificity obtained for the aorto-iliac disease are 
probably higher than those expected in the assessment of IIAS 
because the IIA is deeper and more difficult to evaluate with DUS. 
Some authors have also suggested assessing indirectly the IIA by 
studying the gluteal artery with DUS but the results have to be 
confirmed on larger population (32).
Computerized-tomodensitometric angiography (CTA) and 
magnetic-resonance angiography (MRA), “semi-invasive” exams, 
can be an option for the diagnosis of IIAS especially when a 
patient is candidate for revascularization (Figure 2) (11).
Digital subtraction angiography, an invasive technique 
remains the gold standard for the diagnosis of IIAS with oblique 
projections to avoid missing the diagnosis of IIAS (11). Indeed, 
the external iliac artery hides the IIA at the level of gluteal canal 
on antero-posterior views (33). Moreover, as suggested by the 
American College of Cardiology (ACC) and the AHA, when 
conducting a diagnostic lower extremity arteriogram in which 
the significance of an obstructive lesion is ambiguous, trans-
stenotic pressure gradients should be obtained (2). The cut-off of 
mean resting gradient to determine whether or not the stenosis 
is significant is discussed ranging from 5 (34) to 10 mm Hg (35). 
The peripheral fractional flow reserve (p-FFR), which is defined 
as the ratio of the mean pressure distal to the stenosis to the mean 
aortic pressure at hyperemia, could also be a valuable test (36–38).
Functional Assessment of IIAS During Walking
Both exercise transcutaneous oxygen pressure (Exercise-TcPO2) 
and exercise near-infrared spectroscopy (NIRS) measure-
ments performed on treadmill have been proposed to estimate 
exercise-induced ischemia at the buttock level (3, 37, 39, 40). 
Exercise-TcPO2 reflects skin oxygenation whereas NIRS reflects 
muscles oxygenation. Nevertheless, at the buttock level at least, 
the skin and muscles below are vascularized by the same arterial 
trunk, the internal artery. Compared in the same study, NIRS and 
Exercise-TcPO2 provided, respectively, 55% (range, 41.6–67.9%) 
and 82% (range, 69.6–90.5%) accuracy (95% confidence interval) 
to predict the presence of arteriographically proven lesions (41). 
The Exercise-TcPO2 has 79% sensibility and 86% specificity to 
detect significant lesions (stenosis ≥75%) in the arterial tree 
of the pelvic circulation when the cut-off point is lower than 
−15 mm Hg (3) (Figure 3). The Exercise-NIRS provides a non-
invasive method of measuring tissue oxygen saturation [StO(2)]. 
FiGURe 2 | Results of computerized-tomodensitometric angiography: 
occlusion of the right internal iliac artery. Arrow, occlusion of the right 
internal iliac artery.
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Different parameters have been proposed using different treadmill 
protocols (39, 42, 43). Time to 50% of StO(2) recovery to baseline 
[T(50)] >70  s yielded a sensitivity of 89% and a specificity of 
85% for PAD (42). To predict a significant lesion on the arteries 
toward the hypogastric circulation, a recovery time >240 s was 
considered as a cut-off value (39).
Management
There is no specific management of IIAS (4, 11). The medical 
management is the same as for LEAD. To reduce adverse cardio-
vascular events such as stroke and acute myocardial infarction, 
lifelong therapy should include elimination or modification of 
atherosclerotic modifiable risk factors such as smoking, hyper-
tension, diabetes mellitus, and dyslipidemia (11). Daily exercise 
and favorable diet limiting the atherosclerotic process are recom-
mended (9, 11). Revascularization indication depends on the 
patient functional impairment (e.g., normal work or other activi-
ties important for the patient) after a lack of adequate response 
to exercise therapy and well-conducted medical treatment (11). 
The morphology of the lesion is also an important criterion for 
the choice of the revascularization (4, 11).
Lifestyle Intervention and Atherosclerotic Risk 
Factors Modifications
Smoking cessation is needed because continuing smoking com-
pared with smoking cessation was found to increase the risk of 
death, myocardial infarction, and amputation (44). Patients who 
are smokers or former smokers should be asked about tobacco 
use status at every visit and be assisted to stop (11). The WHO 
study group has proposed that guidelines for the prevention 
of cardiovascular disease include a diet low in fat (<30% of 
calories) and saturated fatty acids (<10% of calories) and devoid 
of trans fatty (saturated) acids. Salt intake should be reduced 
to 5 g/d (90 mmol/d). Consumption of a broad range of fruits, 
vegetables (>400  g/d corresponding to five intakes per day) is 
FiGURe 3 | Procedure of exercise-TcPO2 in one patient. Case history: a 
59-year-old woman, former smoker with a history of hypertension and 
hyperlipidemia always reports pain in her right buttock when she walks although 
she had surgery for lumbar spinal stenosis 2 years before. The discomfort has 
progressively worsened over the past 4 months and now forces her to rest after 
walking 250 m at a normal pace. The pain is interfering with her ability to 
perform her job. She has a normal right femoral pulse and normal ankle-brachial 
index. (A): patient on a treadmill with five probes of TcPO2 (one on each buttock, 
one on each calf, and one on the chest) and a 12-lead electrocardiogram. 
Upper right (B): schema of a TcPO2 probe. Lower right (C): typical recordings of 
Exercise-TcPO2 measurements showing a right buttock ischemia with a DROP 
(delta from rest of oxygen pressure) lower than −15 mm Hg.
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encouraged (45). Thus, dietary assessment has to be done in clini-
cal practice with specific validated tool (46).
Patients with proximal claudication could benefit from home-
based exercise program or supervised exercise training with at 
least three sessions of 35 to 45 min per week for a minimum of 
12 weeks (11, 47). Therefore, physical activity has to be highly 
recommended (45).
Medical Treatment
In addition to lifestyle changes, antiplatelet agents as aspirin in 
daily doses of 75–325 mg is recommended as safe and effective 
therapy to reduce the risk of myocardial infarction, stroke, and 
vascular death (48). Clopidogrel (75  mg per day) can be an 
alternative antiplatelet therapy since it appears to be more effec-
tive than aspirin in preventing ischemic events in patients with 
symptomatic LEAD without increasing bleeding events (CAPRIE 
study) (49).
Lipid-lowering drugs are also recommended for all LEAD 
patients to achieve a goal of LDL cholesterol level less than 100 mg 
per dL, and when risk is very high, a LDL cholesterol target of 
less than 70 mg/dL is preferable (11). However, the ACC/AHA 
guidelines published in 2013 have stopped to recommend a 
cholesterol target since clinical trial data do not indicate what the 
target should be. According to these guidelines, in case of athero-
sclerotic cardiovascular disease, a high intensity statin should be 
used for patients aged ≤75 years old or a moderate intensity statin 
for patients aged >75 years old (50). In the Heart Protection Study 
trial, simvastatin (a hydroxymethyl glutaryl (HMG) coenzyme-A 
reductase) has significantly reduced the risk of major vascular 
event by 22% (95% confidence interval: 15–29) in LEAD patients 
as compared to placebo (51). Antihypertensive drugs should be 
administered to LEAD patients with hypertension to achieve a 
goal of <140 mm Hg systolic over 90 mm Hg diastolic (in non-
diabetic patients) or <130 mm Hg systolic over 80 mm Hg diastolic 
(diabetic patients and patients with chronic renal disease) (11). 
The angiotensin-converting enzyme inhibitors (ACEI) should be 
preferred in asymptomatic or symptomatic LEAD to reduce the 
risk of adverse cardiovascular events since ramipril 10  mg/day 
diminished the risk of myocardial infarction, stroke, or vascular 
death in patients with LEAD by approximately 25% (52). Ramipril 
resulted also in significant increases in pain-free and maximum 
treadmill walking times compared with placebo (53). In practice, 
the introduction of ACEI should be done over 1 month by increas-
ing the dose slowly and monitoring the creatinine clearance.
In diabetic patients, antidiabetic drugs should be adminis-
tered to reach a goal of Hemoglobin A1c below 7% to reduce 
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microvascular complications and improve cardiovascular 
 outcomes (11).
Others drugs as cilostazol or pentoxifylline can be used in 
patients with LEAD to improve the walking distance (11).
Revascularization
Revascularization can be proposed to patients who have an 
important walking impairment and after no improvement after 
medical treatment and supervised exercise training (4, 11). In case 
of isolated IIAS, endovascular treatment is the most used procedure 
since surgical revascularization is both technically more demand-
ing and brings along a higher risk to the patient (54, 55). Contrary 
to stenosis concerning the common iliac artery or external iliac 
artery, there is neither randomized comparison of primary stent 
placement versus percutaneous transluminal angioplasty (PTA) 
nor comparison with surgery for IIAS (35, 56). Several studies 
have assessed the endovascular treatment (PTA alone or stenting) 
on short series of patients. Thompson et al. have shown that the 
procedures either for PTA alone or stenting were safe without any 
complication in nine patients with buttock claudication: seven out of 
nine had pain relief after 1 month of follow-up (54). Another study, 
including 21 patients followed during 14.7 ± 5.7 months, found that 
all patients had complete alleviation of the buttock claudication and 
a significant increase of the walking distance from 85 m to 225 m 
after the endovascular treatment (PTA alone or stenting) (55). 
In 2013, Prince et al. have shown that endovascular treatment of 
IIAS has a high technical success rate (i.e., absence or stenosis after 
procedure lower than 30%) and a low complication rate (in 3 out of 
34 patients). In their study (34 patients included), 79% of patients 
had complete or partial pain relief of symptoms (57). Morse et al., 
Smith et al., Adlakha et al., and Huetink et al. have also reported 
different symptomatic cases of IIAS that were successfully treated 
by endovascular procedures (58–61). Batt et al. have also shown 
good results for the angioplasty of the superior gluteal artery lesions 
(13, 62). Paumier et al. have suggested that in case of common iliac 
artery stenosis, aorto-iliac bypasses with a reimplantation of IIA 
should be discussed (63). The same group performed another study 
in 40 patients, in whom a direct revascularization of the IIA was 
performed concomitant to aorto-or iliofemoral bypasses. Proximal 
claudication after revascularization disappeared in 23 out 27 
patients who had previous proximal claudication (64). The patency 
rate of the IIA was 89% at 1 year and 72.5% at 5 years (64).
Areas of Uncertainties
Algorithm of Diagnosis
To date, no algorithm has been proposed to perform the IIAS 
diagnosis taking account the cost of the exams and their possible 
results to help for the diagnosis. Studies are lacking about the 
sensitivity and specificity of several exams such as ultrasound 
exam, CTA, or MRA on the specific IIAS evaluation. Herein, we 
propose our diagnosis algorithm (Figure 4).
FiGURe 4 | Diagnosis algorithm. ABI, ankle-brachial index; Exercise-TcPO2, exercise transcutaneous oxygen pressure measurement; Exercise-NIRS,  
near-infrared spectroscopy; CT, computed tomography.
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